A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile ...

A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

“We’ve been on a decade-long mission to try to understand why that is,” Schneider said. He led a clinical study of Black ...

Young adults face rising cancer rates — and barriers to timely interventions. From now until the end of the year, all ...

The approval was based on data from the randomized, placebo-controlled, double-blind, phase 3 RATIONALE-305 trial.

Metastatic cancer "thrivers" offer hope and inspiration to others with cancer. (Washington Post)A California court ordered ...

The poorest households and those hospitalised were most most likely to suffer ‘catastrophic costs’, according to a study ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy to treat unresectable or metastatic, HER2-, PD-L1+ gastric or GEJ adenocarcinoma.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

The U.S. Department of State has designated Oakmont native Marc Fogel, who has been held in a Russian penal colony for more ...